Navigation Links
John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
Date:5/15/2012

On May 18, John Theurer Cancer Center at HakensackUMC, one of the nation's top 50 cancer centers, will host the 8th Annual Neuro-Oncology Symposium. This year's program, titled New Horizons in Neuro-Oncology- Innovations in the Treatment of Brain Tumors, will bring leading experts to discuss the most important advancements and innovations for the treatment of patients with brain tumors. The symposium will be held on Friday, May 18 from 8:00am to 1:00pm.

"New research and innovations are constantly changing the way we diagnosis, manage, and treat neuro-oncology patients," George Kaptain, M.D., Co-Chief, Brain & Spine Institute, John Theurer Cancer Center "We are excited to bring in leading experts to our center to better understand how we can apply these latest findings to our clinics."

Featured speakers and their presentations include:

  • Gene Barnett, M.D., M.B.A., Director, Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic: Evolution of Radiosurgery and The Cleveland Clinic Experience

  • W. Jeffrey Elias, M.D., Director of Stereotactic and Functional Neurosurgery, University of Virginia Health System: Assessment and Utilization of Focused Ultrasound Surgery

  • Nathan E. Simmons, M.D., Neurosurgery, Dartmouth Hitchcock Medical Center: Efficacy and Limitations in the Use of Quantitative Fluorescence Intracranial Tumor

  • Andrew B. Lassman, M.D., Chief, Neuro-Oncology, New York-Presbyterian Hospital: Glioblastoma: Past, Present and Future

"The neuro-oncology symposium is a great opportunity for tri-state area healthcare professionals to learn about the latest brain tumor advancements from leaders in our field," said Samuel Goldlust, M.D., Co-Chief, Brain & Spine Institute, John Theurer Cancer Center. "Not only is it a very exciting time for progress in neuro-oncology, but also for our cancer center. With the recent opening of our Gamma Knife radiosurgery center and our robust clinical trials program we have helped to bring cutting-edge care for brain tumor patients to Northern New Jersey."

"Now in our eighth year, we look forward to hosting this program at our new, state-of-the-art cancer building," said Mark S. Pascal, M.D., Chief of Nero-Oncology, John Theurer Cancer Center. "Our comprehensive cancer facility brings our 14 divisions together under one roof, and encourages collaboration and a multidisciplinary approach among practicing physicians and staff."

The conference is located at John Theurer Cancer Center, 92 Second Street, Hackensack, NJ. This conference is complimentary, however registration is required. Please contact Maryann V. Lederhilger at 551-996-1162 or MLederhilger@HackensackUMC.org.

This conference is primarily for neuro and medical oncologists, neurologists, neurosurgeons, radiation therapists, neuro-radiologists and primary care physicians as well as other healthcare professionals involved in the treatment of brain and spinal tumor patients. HackensackUMC designates this education activity for a maximum of 4.0 AMA PRA Category 1 Credits.

"This symposium is part of John Theurer Cancer Center's commitment to help physicians and other healthcare professionals remain on the forefront of cancer care through continuing medical education programs," said Andrew L Pecora, M.D., F.A.C.P., C.P.E, Chief Innovations Officer, Professor, and Vice President of Cancer Services.


'/>"/>

Contact: Amy Leahing
aleahing@p4strategy.com
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
2. John Theurer Cancer Center offers breakthrough radiation measurement technology
3. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
4. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
5. The John Theurer Cancer Center recognizes medical physics team for safety track record
6. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
7. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
8. John Theurer Cancer Center to present innovative research at 2 surgical meetings
9. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
10. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
11. Oncology basic research director at John Theurer Cancer Center continues transplantation research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: